6 months ago
IBRX
AnalystsJoseph CatanzaroJoseph Catanzaro's Stock Forecasts
AnalystsJoseph Catanzaro
Analyst Ranking
Bottom 5%
#4512 out of 4706 analysts
Average Return
-10.18%
Win Rate
28%20 out of 71
Risk vs Reward
Poor
Good
Joseph Catanzaro's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +235.60% | $26.18 | $87.86 | 2020-04-22 - 2020-10-22 | Strong Buy |
Biomea Fusion IncBMEA | +151.45% | $4.14 | $10.41 | 2024-06-06 - 2024-10-14 | Strong Buy |
Ocular Therapeutix IncOCUL | +150.14% | $7.40 | $18.51 | 2020-03-04 - 2021-03-05 | Strong Buy |
Halozyme Therapeutics IncHALO | +145.03% | $19.97 | $48.92 | 2020-02-04 - 2021-02-05 | Strong Buy |
Immunogen IncIMGN | +138.34% | $12.26 | $29.22 | 2023-05-02 - 2023-12-04 | Strong Buy |
Joseph Catanzaro Analyst Color
Get additional color on Joseph Catanzaro's coverage of popular stocks
8 months ago
IOVA
Joseph Catanzaro's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immatics NvIMTX | 1 | Strong Buy | $19.00 | +104.41% | Initiates Coverage On | 8 days ago |
Black Diamond Therapeutics IncBDTX | 3 | Strong Buy | $15.00 | +331.03% | Maintains | 22 days ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $95.00 | +11.70% | Maintains | a month ago |
Aadi Bioscience IncAADI | 3 | Hold | $1.75 | -18.60% | Downgrades | 2 months ago |
Turnstone Biologics CorpTSBX | 2 | Strong Buy | $3.75 | +720.57% | Maintains | 2 months ago |
Immunitybio IncIBRX | 5 | Hold | $4.75 | +27.69% | Maintains | 2 months ago |
Lenz Therapeutics IncLENZ | 2 | Strong Buy | $36.00 | +41.18% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 7 | Hold | $10.00 | +2.35% | Downgrades | 3 months ago |
Day One Biopharmaceuticals IncDAWN | 5 | Strong Buy | $40.00 | +179.72% | Maintains | 3 months ago |
Ocular Therapeutix IncOCUL | 4 | Strong Buy | $15.00 | +43.40% | Maintains | 4 months ago |
Biomea Fusion IncBMEA | 4 | Strong Buy | $10.00 | -3.94% | Maintains | 4 months ago |
Halozyme Therapeutics IncHALO | 4 | Hold | $51.00 | -5.47% | Downgrades | 4 months ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $35.00 | +39.11% | Maintains | 4 months ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $3.50 | +221.10% | Upgrades | 5 months ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $4.50 | +126.13% | Initiates Coverage On | 5 months ago |
Acrivon Therapeutics IncACRV | 2 | Strong Buy | $30.00 | +313.22% | Maintains | 6 months ago |
Boundless Bio IncBOLD | 1 | Strong Buy | $20.00 | +562.25% | Initiates Coverage On | 6 months ago |
Achilles Therapeutics PLCACHL | 3 | Hold | $2.00 | +103.05% | Downgrades | 6 months ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | +73.55% | Maintains | 7 months ago |
I MabIMAB | 4 | Strong Buy | $10.00 | +624.64% | Maintains | 7 months ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $43.00 | -12.64% | Initiates Coverage On | 7 months ago |
Cardiff Oncology IncCRDF | 3 | Strong Buy | $7.00 | +166.16% | Maintains | 7 months ago |
Schrodinger IncSDGR | 2 | Strong Buy | $50.00 | +180.43% | Maintains | 8 months ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $18.00 | +163.16% | Initiates Coverage On | 8 months ago |
Gracell Biotechnologies IncGRCL | 1 | Hold | $10.00 | -2.44% | Downgrades | 10 months ago |
Immunogen IncIMGN | 2 | Hold | $31.00 | -0.74% | Downgrades | 10 months ago |
Repare Therapeutics IncRPTX | 3 | Strong Buy | $25.00 | +637.46% | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 1 | Hold | $58.00 | N/A | Downgrades | a year ago |
Rain Oncology IncRAIN | 2 | Hold | $1.75 | N/A | Downgrades | a year ago |
Exelixis IncEXEL | 1 | Strong Buy | $28.00 | N/A | Assumes | a year ago |
Catalyst Pharmaceuticals IncCPRX | 1 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Hold | $11.00 | N/A | Downgrades | 2 years ago |
Harpoon Therapeutics IncHARP | 2 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Essa Pharma IncEPIX | 1 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Connect Biopharma Holdings LtdCNTB | 1 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 1 | Strong Buy | $125.00 | N/A | Maintains | 3 years ago |
Figs IncFIGS | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Marker Therapeutics IncMRKR | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 4 years ago |
Seagen IncSGEN | 2 | Hold | $170.00 | N/A | Maintains | 4 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $40.00 | N/A | Maintains | 4 years ago |
Xbiotech IncXBIT | 2 | Strong Buy | $18.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.